Purchases and Sales Made in Q4 2021 in Achilles Therapeutics PLC (ACHL)
This table provides information about the institutional ownership of Achilles Therapeutics PLC (ACHL) during Q4 2021. The information is specifically focused on institutions that hold shares of Achilles Therapeutics plc.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 11, 2022
Q4 2021
|
Syncona Portfolio LTD
Guernsey, Channel Islands, X0 |
BUY
|
- |
11.1MNew |
$46.8M - $98.2M
|
11.1M
$12.9M
|
|
Feb 14, 2022
Q4 2021
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
BUY
|
- |
500K+ 100.0% |
$2.11M - $4.43M
|
1M
$1.16M
|
|
Feb 14, 2022
Q4 2021
|
Woodline Partners LP
San Francisco, CA |
BUY
|
- |
324KNew |
$1.37M - $2.87M
|
324K
$376K
|
|
Feb 10, 2022
Q4 2021
|
Black Rock Inc.
New York, NY |
BUY
|
- |
212KNew |
$896K - $1.88M
|
212K
$246K
|
|
Feb 14, 2022
Q4 2021
|
Sender CO & Partners, Inc.
New York, NY |
BUY
|
- |
27.7KNew |
$117K - $245K
|
27.7K
$32.1K
|
|
Feb 11, 2022
Q4 2021
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
25.5KNew |
$108K - $226K
|
25.5K
$29.6K
|
|
Feb 14, 2022
Q4 2021
|
Legal & General Group PLC
London, X0 |
BUY
|
- |
24.8KNew |
$104K - $219K
|
24.8K
$28.7K
|
|
Feb 14, 2022
Q4 2021
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
17.3K+ 44.08% |
$73K - $153K
|
56.6K
$65.6K
|
|
Feb 14, 2022
Q4 2021
|
Goldman Sachs Group Inc
New York, NY |
BUY
|
- |
13KNew |
$54.9K - $115K
|
13K
$15.1K
|
|
Feb 14, 2022
Q4 2021
|
Rtw Investments, LP
New York, NY |
BUY
|
- |
12.2KNew |
$51.6K - $108K
|
12.2K
$14.2K
|
|
Feb 10, 2022
Q4 2021
|
Jump Financial, LLC
Chicago, IL |
BUY
|
- |
11KNew |
$46.4K - $97.5K
|
11K
$12.8K
|
|
Feb 14, 2022
Q4 2021
|
Morgan Stanley
New York, NY |
BUY
|
- |
6.35KNew |
$26.8K - $56.3K
|
6.35K
$7.36K
|
|
Feb 14, 2022
Q4 2021
|
Ubs Group Ag
|
BUY
|
- |
5.02KNew |
$21.2K - $44.5K
|
5.02K
$5.82K
|
|
Feb 10, 2022
Q4 2021
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
3.44KNew |
$14.5K - $30.5K
|
3.44K
$3.99K
|
|
Feb 14, 2022
Q4 2021
|
Axa S.A.
Paris, I0 |
BUY
|
- |
3.37K+ 1.21% |
$14.2K - $29.8K
|
283K
$328K
|
|
Feb 08, 2022
Q4 2021
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
2.16K+ 91.3% |
$9.12K - $19.1K
|
4.53K
$5.25K
|
|
Feb 10, 2022
Q4 2021
|
Citigroup Inc
|
BUY
|
- |
1.19KNew |
$5K - $10.5K
|
1.19K
$1.37K
|
|
Jan 19, 2022
Q4 2021
|
Endurance Wealth Management, Inc.
|
BUY
|
- |
2New |
$8.44 - $17.7
|
2
$2.32
|
|
Feb 07, 2022
Q4 2021
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Feb 14, 2022
Q4 2021
|
Cubist Systematic Strategies, LLC
Stamford, CT |
SELL
|
- |
-875- 46.42% |
$3.69K - $7.75K
|
1.01K
$1.17K
|
|
Feb 11, 2022
Q4 2021
|
Affinity Asset Advisors, LLC
New York, NY |
SELL
|
- |
-100KClosed |
$422K - $886K
|
0
$0
|
|
Feb 14, 2022
Q4 2021
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
SELL
|
- |
-243KClosed |
$1.02M - $2.15M
|
0
$0
|
|
Feb 14, 2022
Q4 2021
|
Boxer Capital, LLC
San Diego, CA |
SELL
|
- |
-1.54MClosed |
$6.48M - $13.6M
|
0
$0
|